Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 55111-534

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 55111-534). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container (Container)

Container (Container)
Label for Divalproex Sodium Extended-release Tablets, USP 500 mg by Dr. Reddy's Laboratories Ltd, containing 100 film-coated tablets for once-daily dosing. The label includes storage instructions, sealing cautions, and dispensing notes. The product is packaged in a bottle and is marked for prescription use only.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A cumulative response curve comparing Divalproex Sodium Delayed-Release Tablets and placebo, depicting percentage reduction in CPS rate on the vertical axis against percentage of patients on the horizontal axis. The graph shows the effectiveness of Divalproex Sodium relative to placebo with improvement and worsening indicated.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A cumulative distribution plot comparing high dose and low dose Divalproex Sodium delayed-release tablets. The x-axis shows the percentage of patients from 0 to 100%, and the y-axis shows the percentage reduction in CPS rate from -100% (worsening) to 100% (improvement). Two lines represent patient response trends for high dose (solid line) and low dose (dashed line) formulations.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
A bar chart comparing the effects of placebo and Divalproex Sodium extended-release tablets, with numeric values indicated above the bars (0.6 for placebo and 1.2 for Divalproex Sodium). The chart visually represents a numerical difference between the two groups.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of divalproex sodium, showing its molecular components including sodium ion and linked organic groups typical of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.